Cyclo Therapeutics
Why Robinhood?
You can watch CYTH and buy or sell other stocks, ETFs, and their options commission-free!About CYTH
Cyclo Therapeutics, Inc. engages in the development of cyclodextrin-based biopharmaceuticals for the treatment of disease. Its product pipeline include Trappsol Cyclo, which treats Neimann-Pick Type C disease and Alzheimer's disease.
CYTH Key Statistics
Stock Snapshot
Cyclo Therapeutics(CYTH) stock is priced at $0.72, giving the company a market capitalization of 20.62M. It carries a P/E multiple of -0.81.
During the trading day, Cyclo Therapeutics(CYTH) stock saw an opening price of —, a peak of —, and a bottom of —.
Trading activity shows a volume of 0, compared to an average daily volume of 22.85K.
The stock's 52-week range extends from a low of $0.55 to a high of $1.62.
The stock's 52-week range extends from a low of $0.55 to a high of $1.62.
People also own
Similar Marketcap
This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.
Popular Stocks
This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset
Newly Listed
This list is generated by showing companies that recently went public.